Draft genome sequence of Bacillus coagulans GBI-30, 6086, a widely used spore-forming probiotic strain

Genome Announcements

Volumn 2, Issue 6, 2014, Pages

  Orrù, Luigi ^a   Salvetti, Elisa ^b   Cattivelli, Luigi ^a   Lamontanara, Antonella ^a   Michelotti, Vania ^a   Capozzi, Vittorio ^c   Spano, Giuseppe ^c   Keller, David ^d   Cash, Howard ^d   Martina, Alessia ^b   Torriani, Sandra ^b   Felis, Giovanna E ^b  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d Ganeden Biotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85005999207     PISSN: None     EISSN: 21698287     Source Type: Journal    
DOI: 10.1128/genomeA.01080-14     Document Type: Article

References (13)

1. Cutting SM. 2011. Bacillus probiotics. Food Microbiol. 28:214-220. http://dx.doi.org/10.1016/j.fm.2010.03.007.
2. Dolin BJ. 2009. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find. Exp. Clin. Pharmacol. 31:655-659. http://dx.doi.org/10.1358/mf.2009.31.10.1441078.
3. Hun L. 2009. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad. Med. 121:119-124. http://dx.doi.org/10.3810/pgm.2009.03.1984.
4. Kalman DS, Schwartz HI, Alvarez P, Feldman S, Pezzullo JC, Krieger DR. 2009. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulansbased product on functional intestinal gas symptoms. BMC Gastroenterol. 9:85. http://dx.doi.org/10.1186/1471-230X-9-85.
5. Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Farmer S, Keller D. 2012 Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-induced colitis following vancomycin withdrawal in mice. Gut Pathog. 4:13. http://www.gutpathogens.com/content/4/1/13.
6. Mandel DR, Eichas K, Holmes J. 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement. Altern. Med. 10:1. http://dx.doi.org/10.1186/1472-6882-10-1.
7. Jurenka JS. 2012. Bacillus coagulans. Altern. Med. Rev. 17:76-81.
8. Barbosa TM, Serra CR, La Ragione RM, Woodward MJ, Henriques AO. 2005 Screening for Bacillus isolates in the broiler gastrointestinal tract. Appl. Environ. Microbiol. 71:968-978. http://dx.doi.org/10.1128/AEM.71.2.968-978.2005.
9. Su F, Tao F, Tang H, Xu P. 2012. Genome sequence of the thermophile Bacillus coagulans hammer, the type strain of the species. J. Bacteriol. 194:6294-6295. http://dx.doi.org/10.1128/JB.01380-12.
10. Su F, Xu P. 2014. Genomic analysis of thermophilic Bacillus coagulans strains: efficient producers for platform bio-chemicals. Scientific Rep. 4:1-10. http://dx.doi.org/10.1038/srep03926.
11. Rhee MS, Moritz BE, Xie G, del Rio TG, Dalin E, Tice H, Bruce D, Goodwin L, Chertkov O, Brettin T, Han C, Detter C, Pitluck S, Land ML, Patel M, Ou M, Harbrucker R, Ingrram LO, Shanmugam KT. 2011. Complete genome sequence of a thermotolerant sporogenic lactic acid bacterium, Bacillus coagulans strain 36D1. Stand Genomics Sci. 5:331-340. http://dx.doi.org/10.4056/sigs.2365342.
12. Su F, Xu K, Zhao B, Tai C, Tao F, Tang H, Xu P. 2011. Genome sequence of the thermophilic strain Bacillus coagulans XZL4, an efficient pentose-utilizing producer of chemicals. J. Bacteriol. 193:6398-6399. http://dx.doi.org/10.1128/JB.06157-11.
13. Xu K, Su F, Tao F, Li C, Ni J, Xu P. 2013. Genome sequences of two morphologically distinct and thermophilic Bacillus coagulans strains, H-1 and XZL9. Genome Announc. 1(3):e00254-13. http://dx.doi.org/10.1128/genomeA.00254-13.